response
OBJECTIVE: The response to single disease modifying antirheumatic drug (DMARD) is       often suboptimal in patients with rheumatoid arthritis (RA).
OBJECTIVE: The  @SUBJECT$  to single disease modifying antirheumatic drug (DMARD) is       often suboptimal  @PREDICAT$   @OBJECT$  with rheumatoid arthritis (RA).